Clessidra Capital Credit SGR participates in a club deal to delist Health Italia from Euronext Growth Milan, aiming to enhance its integrated healthcare offerings and market position.
Information on the Target
Health Italia is a prominent player in the health and wellness sector in Italy, focusing on integrated healthcare services. The company is poised for a significant transformation as it prepares for a delisting from Euronext Growth Milan, which aims to enhance its operational framework and market offerings.
The upcoming deal will be facilitated by Clessidra Capital Credit SGR, a subsidiary of Clessidra Holding, alongside a private investor club led by experienced industry leaders Giovanni Giuliani and Stefano Pellegrino. The strategic initiative seeks to fortify Health Italia's position as a reference platform for integrated healthcare services.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare sector in Italy is undergoing substantial evolution, driven by increasing demand for integrated healthcare services and well-being solutions.
Similar Deals
Silver Economy Fund → Medical International Research (Mir)
2025
Silver Economy Fund → Mir-Medical International Research
2025
Quadrivio Group → Mir (Medical International Research)
2025
Silver Economy Fund → MIR – Medical International Research
2025
Silver Economy Fund (Quadrivio) → Biotec Italia
2025
Clessidra Capital Credit
invested in
Health Italia
in 2025
in a Buyout deal